A highly sensitive assay for angiotensin I converting enzyme has been developed by using angiotensin I as a substrate. Angiotensin II generated in the reaction mixture was measured by a newly developed specific radioimmunoassay. To protect against angiotensin II destruction, bestatin, an inhibitor of angiotensinases, was added to the reaction mixture. Pepstatin, an inhibitor of renin, was also used to inhibit plasma renin activity. The reaction was stopped by adding EDTA and MK-521, inhibitors of angiotensin I converting enzyme. The specificity of the antiserum used for the angiotensin II radioimmunoassay was very high. The cross reactivity with angiotensin I was less than 0.5% and none of the proteolytic enzyme inhibitors crossreacted in the assay. The inhibitory effect of pepstatin on plasma renin activity was very high (more than 80%) under the standard assay conditions employed. Serum angiotensinase activity was completely inhibited by the addition of bestatin. An excellent correlation was obtained between this new method and the spectrophotometric method using a synthetic substrate, Hip-His-Leu. The generation of as little as 12pM of Angiotensin II can be detected. Such low concentration have not been measurable with the usual spectrophotometric method. This new method will facilitate clinical and experimental studies on this unique enzyme, since very low levels of activity can be determined by this highly sensitive radioimmunoassay for angiotensin II.
Angiotensin I converting enzyme (ACE) (E.C.3.4.15.1, kininase II) reacts with the inactive peptide, angiotensin I (AI), liberating the carboxy terminal dipeptide, HistidylLeucine, and the vasoactive octapeptide, angiotensin II (AII) (recently reviewed by Das and Soffer, 1975; Soffer, 1976) .
To measure ACE activity, a spectrophotometric method (Cushman and Cheung, 1971) or its modification (Lieberman, 1975) using synthetic substrate (Hippuryl-Histidyl-Leucine: Hip-His-Leu) is generally employed. However, the sensitivity of this method is not sufficient to assess low levels of activity. Another method used in the determination of this enzyme activity has been described. Hollemans et al. (1969) and Poulsen et al. (1971) reported a radioimmunoassay method for All converted from AI. A drawback in this latter method is that All may be destroyed by serum angiotensinases (ATase) and that generation of AI by plasma renin activity may occur during the incubation of the reaction mixture. In this paper, we report a highly sensitive method for measuring ACE activity using AI as a substrate, in which, AI, the intrinsic substrate for ACE, is converted to All in the reaction. Generated All is determined by All radioimmunoassay, without All destruction by angiotensiases.
Materials and Methods
Hippuryl-Histidyl-Leucine(Hip-His-Leu),bradykinin-potentiating peptide (BPP), angiotensin I (AI), angiotensin II (AII) , and bestatin were purchased from Protein Research Foundation, Osaka, Japan. N-Carboxy-dipeptide-lysine analog (MK-521: Patchett , et al., 1980) was supplied by Merck Sharp and Dohme Research Laboratories.
Pepstatin A was donated by Dr. T. Aoyagi, Institute of Microbial Chemistry, Tokyo, Japan. 125I AI and 125I All were purchased from New England Nuclear Co., Boston, USA. HEPES (N-2-hydroxyethylpiperazin-N"-2-ethanosulfonic acid) was purchased from Calbiochem Co., California, USA. Antiserum to All was produced in rabbits by the use of thyroglobulin-conjugate, recently reported in Hidaka et al. (1982) . Our method is essentially based on that of Goodfriend et al. (1964) . AIIconjugate was prepared by the method as follows; Briefly, 10mg of Porcine thyroglobulin and 20 mg of All were dissolved in 0.5ml of water. To this mixture, 0.25ml of water containg 100 mg of 1-cyclohexyl-3(2-morpho-linoethyl)-carbodiimide-metho-P-toluenesulfonate was added as a coupling agent. The copolymer was dialized against distilled water for 24 hrs., lyophilized and then emulsified into complete Freund's adjuvant for immunization.
0.1mg mixture (1: 1) of Freund's adjuant and AII-conjugate was injected into the toe-pads and leg muscles of rabbits. Boosting was performed monthly by intraperitoneal administration over six months. The best titer of antiserum obtained was more than 1: 100,000 with an initial binding of 50% (B/F=1).
The cross reactivities to angiotensin analogue and various reagents in ACE assay have been reported by Hidaka et al. (1982) .
Other reagents were of analytical grade and were obtained from commercial sources. 
Results and Discussion
Binding rate of All antiserum to 0pg All in the standard curve was 75% in a final dilution of 1:100,000. The interference of AI and the proteolytic enzyme inhibitors with employed All antiserum was examined (Hidaka et al., 1982) . The cross reactivity (50% binding) was as much as 0.5% to AI and none to bestatin, peptatin, or MK-521. The mean recovery of synthetic All (400, 200, 100, 50, 25, and 12.5pg) added to five plasma samples was 100.6% average (109.1-91.3% ranged).
The renin inhibitor, pepstatin, was added to the reaction mixture. By using pepstatin in the assay system we were able to ensure the quantity of substrate AI, since the pepstatin stopped the intrinsic production of AI. The inhibitory effect of pepstatin on plasma renin was examined; The 50% in- 
